MAGED1
Basic information
Region (hg38): X:51803007-51902354
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MAGED1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 6 | |||||
missense | 27 | 31 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 28 | 5 | 4 |
Variants in MAGED1
This is a list of pathogenic ClinVar variants found in the MAGED1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
X-51894655-A-G | not specified | Likely benign (Dec 03, 2021) | ||
X-51894750-G-A | Benign (Dec 31, 2019) | |||
X-51894774-C-T | not specified | Uncertain significance (Apr 15, 2024) | ||
X-51894787-C-T | not specified | Likely benign (Nov 01, 2022) | ||
X-51895058-G-C | not specified | Uncertain significance (Oct 27, 2022) | ||
X-51895136-C-G | not specified | Uncertain significance (Dec 19, 2022) | ||
X-51895140-G-A | not specified | Uncertain significance (Dec 07, 2021) | ||
X-51895182-G-A | not specified | Uncertain significance (Feb 22, 2023) | ||
X-51895203-C-G | not specified | Uncertain significance (Jan 09, 2023) | ||
X-51895314-G-A | not specified | Likely benign (Sep 26, 2022) | ||
X-51895420-C-A | not specified | Uncertain significance (Jan 22, 2024) | ||
X-51895508-C-T | Uncertain significance (Aug 01, 2017) | |||
X-51895557-T-C | not specified | Uncertain significance (Feb 05, 2024) | ||
X-51895605-G-A | not specified | Uncertain significance (Jul 08, 2022) | ||
X-51895639-A-G | not specified | Uncertain significance (Jan 19, 2024) | ||
X-51895693-C-T | not specified | Uncertain significance (Apr 05, 2023) | ||
X-51895755-C-T | not specified | Uncertain significance (Apr 07, 2022) | ||
X-51895758-A-G | not specified | Uncertain significance (Apr 23, 2024) | ||
X-51896520-G-C | not specified | Uncertain significance (Apr 19, 2024) | ||
X-51896523-G-A | not specified | Uncertain significance (Sep 16, 2021) | ||
X-51896530-C-G | not specified | Uncertain significance (Dec 21, 2023) | ||
X-51896549-G-A | Likely benign (Feb 09, 2018) | |||
X-51896613-C-T | not specified | Uncertain significance (May 15, 2024) | ||
X-51896650-G-T | not specified | Uncertain significance (Nov 07, 2022) | ||
X-51896664-G-A | not specified | Uncertain significance (Oct 05, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MAGED1 | protein_coding | protein_coding | ENST00000375695 | 12 | 99351 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.998 | 0.00169 | 125698 | 4 | 10 | 125712 | 0.0000557 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.33 | 210 | 329 | 0.639 | 0.0000252 | 5420 |
Missense in Polyphen | 15 | 63.709 | 0.23545 | 1142 | ||
Synonymous | 1.34 | 103 | 122 | 0.846 | 0.00000924 | 1706 |
Loss of Function | 4.50 | 2 | 27.4 | 0.0729 | 0.00000198 | 410 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000112 | 0.000112 |
Ashkenazi Jewish | 0.000134 | 0.0000992 |
East Asian | 0.00 | 0.00 |
Finnish | 0.0000648 | 0.0000462 |
European (Non-Finnish) | 0.000100 | 0.0000703 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.000226 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Involved in the apoptotic response after nerve growth factor (NGF) binding in neuronal cells. Inhibits cell cycle progression, and facilitates NGFR-mediated apoptosis. May act as a regulator of the function of DLX family members. May enhance ubiquitin ligase activity of RING-type zinc finger-containing E3 ubiquitin-protein ligases. Proposed to act through recruitment and/or stabilization of the Ubl-conjugating enzyme (E2) at the E3:substrate complex. Plays a role in the circadian rhythm regulation. May act as RORA co-regulator, modulating the expression of core clock genes such as ARNTL/BMAL1 and NFIL3, induced, or NR1D1, repressed. {ECO:0000269|PubMed:20864041}.;
- Pathway
- Neurotrophin signaling pathway - Homo sapiens (human);Signal Transduction;Caspase activation via extrinsic apoptotic signalling pathway;Apoptosis;Programmed Cell Death;NRAGE signals death through JNK;Ligand-independent caspase activation via DCC;Death Receptor Signalling;p75 NTR receptor-mediated signalling;Neurotrophic factor-mediated Trk receptor signaling;p75(NTR)-mediated signaling;Cell death signalling via NRAGE, NRIF and NADE
(Consensus)
Recessive Scores
- pRec
- 0.136
Intolerance Scores
- loftool
- 0.600
- rvis_EVS
- -0.54
- rvis_percentile_EVS
- 20.54
Haploinsufficiency Scores
- pHI
- 0.329
- hipred
- Y
- hipred_score
- 0.633
- ghis
- 0.539
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.881
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Maged1
- Phenotype
- integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); cellular phenotype; immune system phenotype; homeostasis/metabolism phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); vision/eye phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan);
Gene ontology
- Biological process
- regulation of transcription, DNA-templated;regulation of transcription by RNA polymerase II;circadian regulation of gene expression;regulation of circadian rhythm;regulation of apoptotic process;positive regulation of MAP kinase activity;negative regulation of transcription, DNA-templated;positive regulation of transcription, DNA-templated;negative regulation of epithelial cell proliferation;positive regulation of branching involved in ureteric bud morphogenesis;positive regulation of apoptotic signaling pathway
- Cellular component
- chromatin;nucleus;cytoplasm;plasma membrane;protein-containing complex
- Molecular function
- transcription coactivator activity;protein binding;identical protein binding